How patient reporters identify adverse drug reactions: A qualitative study of reporting via the UK yellow card scheme

Drug Safety

Volumn 34, Issue 5, 2011, Pages 429-436

  Krska, Janet ^a   Anderson, Claire ^b   Murphy, Elizabeth ^c   Avery, Anthony J ^b  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Adverse reaction monitoring; Pharmacovigilance; Postmarketing surveillance; Questionnaires

Indexed keywords

AMLODIPINE; BENDROFLUMETHIAZIDE; CITALOPRAM; DIANE; IBUPROFEN; INDAPAMIDE; LOSARTAN POTASSIUM; PAROXETINE; SIMVASTATIN; VENLAFAXINE;

ADULT; ADVERSE DRUG REACTION; AGED; AGITATION; ANXIETY; ARTICLE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FEMALE; HEALTH PRACTITIONER; HUMAN; INSOMNIA; INTERVIEW; LEG CRAMP; MAJOR CLINICAL STUDY; MALE; MUSCLE CONTRACTION; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUESTIONNAIRE; SIDE EFFECT; SUICIDAL IDEATION; UNSPECIFIED SIDE EFFECT;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GREAT BRITAIN; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES; YOUNG ADULT;

EID: 79955414650     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11589320-000000000-00000     Document Type: Article

References (26)

1. World Health Organisation. Consumer reporting of adverse drug reactions.WHO Drug Inf 2000; 14 (4): 211-5 [online]. Available from URL: http://apps.who.int/medicinedocs/ pdf/s2201e/s2201e.pdf [Accessed 2010 Jan 29]
2. Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29: 385-96
3. Hammond IW, Rich D. Consumers usurp spontaneous adverse event reporting in the United States. Pharmacoepidemiol Drug Saf 2005; 14 Suppl 2.: S8-9
4. Avery AJ, Anderson C, Bond CM, et al. Evaluation of patient reporting of adverse drug reactions to theUK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. In press
5. Medicines and Healthcare Regulatory Agency. Patient reporting of suspected adverse drug reactions [online]. Available from URL: http://www.mhra.gov.uk/Safetyinforma tion/Reportingsafetyproblems/ Reportingsuspectedadverse drugreactions/Patientreporting/index.htm [Accessed 2010 Apr 23]
6. Cumber S, Heffer S, Ganhdi S, et al. The Yellow Card Scheme: experience of patient reporting of adverse drug reactions five years since launch [abstract]. Pharmacoepidemiol Drug Saf 2010; 19 Suppl. 1: S321
7. ImprovingADRreporting [editorial]. Lancet 2002; 360: 1435
8. Blenkinsopp A, Wilkie P, Wang M, et al. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2006; 63 (2): 148-56
9. Herxheimer A, Crombag R, Alves TL. Direct patient reporting of adverse drug reactions: a fifteen-country survey and literature review [online]. Available from URL: http://www.haiweb.org/10052010/10-May-2010-Report- Direct-Patient-Reporting-of-ADRs.pdf [Accessed 2010 Jun 8]
10. de Langen J, van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 2008; 31: 515-24 (Pubitemid 351693684)
11. Aagaard L, Nielsen LH, Hansen EH. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 2009; 32: 1067-74
12. McLernon DJ, Bond CM, Hannaford PC, et al., on behalf of the Yellow Card Study Collaboration. Adverse drug reaction reporting in the UK: a retrospective observational comparison of Yellow Card reports submitted by patients and healthcare professionals. Drug Saf 2010; 33: 775-88
13. van Grootheest K, de Graaf L, de Jong-van den Berg LTW. Consumer adverse drug reaction reporting: a new step in pharmacovigilance? Drug Saf 2003; 26: 211-7 (Pubitemid 36363604)
14. McLernon DJ, Bond CM, Lee AJ, et al., on behalf of the Yellow Card Study Collaboration. Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK. Pharmacoepidemiol Drug Saf. Epub 2011 Feb 17
15. Naranjo CA, Busto U, Sellers EM, et al. A method for assessing the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45 (Pubitemid 12149145)
16. Perry BA, Turner LW. A prediction model for polypharmacy: are older, educated women more susceptible to an adverse drug event? J Women Aging 2001; 13: 39-51 (Pubitemid 33664077)
17. Zopf Y, Rabe C, Neubert A, et al. Women encounter ADRs more often than do men. Eur J Clin Pharmacol 2008; 64: 999-1004
18. DeWitt JE, Sorofman BA. A model for understanding patient attributions of adverse drug reaction symptoms. Drug Inf J 1999; 33: 907-20 (Pubitemid 29399786)
19. Hughes ML, Whittlesea CMC, Luscombe DK. Symptom or adverse drug reaction? An investigation into how symptoms are recognised as side-effects of medicines. Pharm J 2002; 269: 719-22 (Pubitemid 35378916)
20. Jarernsiripornkul N, Krska J, Richards RME, et al. Patient reporting of adverse drug reactions: useful information for pain management? Eur J Pain 2003; 7: 219-24 (Pubitemid 36565923)
21. Mannesse CK, Derkx FHM, de Ridder MAJ, et al. Do older hospital patients recognize adverse drug reactions? Age Ageing 2000; 29: 79-81 (Pubitemid 30055069)
22. Petrie KJ,Moss-Morris R, Grey C, et al. The relationship of negative affect and perceived sensitivity to symptom reporting following vaccination. Br J Health Psychol 2004; 9: 101-11 (Pubitemid 38209200)
23. van Grootheest AC, de Jong-van den Berg L. Review: patients' role in reporting adverse drug reactions. Exp Opin Drug Saf 2004; 3: 363-8
24. Golomb BA, McGraw JJ, Evans MA, et al. Physician response to patient reports of adverse drug effects. Drug Saf 2007; 30: 669-75
25. Anderson C, Krska J, Murphy A, et al., on behalf of the Yellow Card Study Collaboration. The importance of direct patient reporting of ADRs: a patient perspective. Br J Clin Pharmacol. In press
26. Medicines and Healthcare Regulatory Agency. Drug analysis prints [online]. Available from URL: http://www. mhra.gov.uk/Onlineservices/Medicines/ Druganalysisprints/ index.htm [Accessed 2011 Jan 17]